Effect of Exercise Prescription on Quality of Life of Patients after Percutaneous Coronary Intervention

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200058406

Enrollment

Unknown

Registered

2022-04-08

Start date

2022-04-01

Completion date

Unknown

Last updated

2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unstable angina pectoris after percutaneous coronary intervention

Interventions

1:Routine drug treatment after PCI

2:Routine drug therapy + anti resistance exercise prescription after PCI

3:Routine drug treatment after PCI + anti resistance exercise prescription + vigorous walking exercise prescription

4:Routine drug treatment after PCI + anti resistance exercise prescription + Taijiquan walking exercise prescription

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. 18 to 75 years old, regardless of gender; 2. Meet the diagnostic criteria of unstable angina pectoris of coronary heart disease, confirmed by coronary angiography and PCI; 3. Those who did not participate in other clinical trials within 3 months; 4. Voluntarily participate in the trial and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with acute myocardial infarction or patients requiring coronary artery bypass grafting; 2. Patients with severe cardiopulmonary insufficiency, new severe arrhythmia or ECG changes, serious primary diseases such as liver, kidney and hematopoietic system, which affect the quality of life; 3. Patients with severe mental illness and consciousness disorder; 4. Those with physical activity disorders such as musculoskeletal system, impaired motor function and disability; Relative or absolute contraindications of rehabilitation exercise such as decreased blood pressure during exercise; The risk stratification results of cardiac rehabilitation in patients with coronary heart disease were high-risk patients.

Design outcomes

Primary

Measure	Time frame
6-minute walk experiment;Electrocardiogram;	—

Secondary

Measure	Time frame
Cardiac ultrasound;Classification of nyha heart function;NT-proBNP;Seattle angina questionnaire; Self-Rating Anxiety scale;Self-Rating Depression scale;	—

Countries

China

Contacts

Public ContactZhenmin Bai

Beijing Sport University

baizm@bsu.edu.cn+86 15810848662

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026